Xamoterol
From Wikipedia, the free encyclopedia
 |
|
|
Xamoterol
|
|
| Systematic (IUPAC) name | |
| N-[2-[ [2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]morpholine-4-carboxamide | |
| Identifiers | |
| CAS number | |
| ATC code | C01 |
| PubChem | |
| Chemical data | |
| Formula | C16H25N3O5 |
| Mol. mass | 339.387 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Xamoterol is a cardiac stimulant. It works by binding to the β1 adrenergic receptor[1].
[edit] References
- ^ Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4. Page 163
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||
